期刊文献+

2141例鼻咽癌患者病案随访数据分析

Analysis of Medical Records of 2,141 Patients with Nasopharyngeal Carcinoma
原文传递
导出
摘要 目的分析北京市某三级甲等肿瘤专科类医院10年间鼻咽癌患者随访数据,为鼻咽癌的防治提供参考。方法选取2009年1月1日—2018年12月31日某院收治的2141例鼻咽癌患者病案随访数据,通过二次电话随访确保总体有效随访率>90%。采用ICD-10和ICD-O分类,使用单因素方差分析、χ^(2)/Fisher检验比较不同组别差异,Cochran-Armitage趋势性检验结合分析随访结果、时间、年龄、性别、分布特征及变化趋势。结果2009-2018年鼻咽癌患者的总体5年期病案随访生存率为74.1%。生存率在10年间呈上升趋势,患者生存率随年龄升高呈现下降趋势,男性的生存率低于女性。肿瘤部位中鼻咽多壁患者生存率最高,为77.9%,肿瘤病理分类中鳞状细胞肿瘤生存率最高,为74.5%。肿瘤分期中Ⅰ期患者的5年期生存率最高,为92.6%,Ⅳ期最低,为59.1%。初治方式中放射治疗的患者生存率最高,为80.2%,手术及操作生存率最低,为50.5%。结论随访患者构成、疾病特点、随访结果等与我国鼻咽癌的相关文献报道一致,医院应及时评估治疗效果、早期发现复发及转移灶、检测和处理治疗相关并发症、促进功能康复,提高鼻咽癌患者的生存率。 Objectives This study aims to analyze the follow-up data of nasopharyngeal carcinoma patients in a tertiary-level A-class tumor specialist hospital in Beijing over the past 10 years and provide a reference for the prevention and treatment of nasopharyngeal carcinoma.Methods The medical record follow-up data of 2,141 patients with nasopharyngeal carcinoma admitted to a certain hospital from January 1,2009 to December 31,2018 were selected,and a second telephone follow-up was conducted to ensure that the overall effective follow-up rate was>90%.ICD-10 and ICD-O classification were used.One-way analysis of variance and χ^(2)/Fisher test were used to compare the differences among different groups.Cochran-Armitage trend test was used to analyze the follow-up results,time,age,gender,distribution characteristics and change trends.Results The overall 5-year survival rate of medical records follow-up in NPC patients from 2009 to 2018 was 74.1%.The survival rate showed an upward trend over the past 10 years,and then decreased with increasing age.The survival rate of men was lower than that of women.Among tumor locations,patients with nasopharyngeal multi-wall tumors had the highest survival rate,at 77.9%,and among tumor pathological classifications,patients with squamous cell tumors had the highest survival rate,at 74.5%.Among the tumor stages,the 5-year survival rate was the highest for patients in stageⅠ,at 92.6%,and the lowest for patients in stageⅣ,at 59.1%.Among the primary treatments,the survival rate of patients receiving radiotherapy was the highest,at 80.2%,while the survival rate of patients receiving surgery and manipulation was the lowest,at 50.5%.Conclusions The patient composition,disease characteristics,and follow-up Results of the follow-up patients were consistent with those reported in the relevant literature on nasopharyngeal carcinoma in our country.Hospitals should promptly evaluate treatment outcomes,detect recurrence and metastasis at an early stage,detect and manage treatment-related complications,promote functional rehabilitation,and improve the survival rate of NPC patients.
作者 王凯鹏 马宇娇 杨爱平 杨景芳 刘爽 霍宇艳 Wang Kaipeng;Ma Yujiao;Yang Aiping;Yang Jingfang;Liu Shuang;Huo Yuyan(National Cancer Center,National Clinical Research Center for Cancer,Medical Records Office,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;不详)
机构地区 国家癌症中心
出处 《中国病案》 2025年第5期59-63,共5页 Chinese Medical Record
关键词 鼻咽癌 病案 随访 疾病构成 生存分析 Nasopharyngeal carcinoma Medical records Follow-up Disease composition Survival analysis
  • 相关文献

参考文献11

二级参考文献91

  • 1戴建荣,胡逸民,张红志,关莹,张可,王闯.针对患者调强放射治疗计划的剂量学验证[J].中华放射肿瘤学杂志,2004,13(3):229-233. 被引量:65
  • 2张浩亮,于锋,孙子谋.鼻咽癌语音易患因素与难患因素分析[J].海南医学,2004,15(12):5-6. 被引量:2
  • 3王浩,李硕颀,张磊,张静,戴伟.湖南省鼻咽癌非病毒影响因素的条件logistic回归分析[J].中南大学学报(医学版),2005,30(3):356-357. 被引量:8
  • 4CURADO M P,EDWARDS B,SHIN H R,et al.Cancer incidence in five continents,Volume IX.IARC scientific publications No.160[M].Lyon:IARC,2007:67-71.
  • 5PARKNM,CHENVW,FERLAYJ,et al.Comparability and quality control in cancer registration.IARC technical report No.19[M].Lyon:IARC,1994:1-116.
  • 6FELAY J,BURKHARD C,WHELAN S,et al.Check and conversion programs for cancer registries.IARC technical report No.42[M].Lyon:IARC,2005:4-10.
  • 7孔灵芝,赵平.中国肿瘤死亡报告——全国第三次死因回顾抽样调查[R].北京:人民卫生出版社,2010:170-187.
  • 8Emami B,Sethi A,Petruzzelli GJ,et al.Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma.Int J Radiation Oncol Biol Phys,2003,57:481-488.
  • 9Kam MK,Chau RM,Petruzzeli GJ,et al.Intensity-modulated radiotherapy in nasopharyngeal carcinoma:dosimetric advantage over conventional plans and feasibility of dose escalation.Int J Radiat Oncol Biol Phys,2003,56:145-57.
  • 10Cozzi L,Fogliata A,Bolsi A,et al.Three-dimensional conformal vs.intensity-modulated radiotherapy in head-and-neck cancer patients:comparative analysis of dosimetric and technical parameter.Int J Radiat Oncol Biol Phys,2004,58:617-624.

共引文献636

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部